Jose Gonzalez, MD
Emergency Medicine · Miami, FLNPI 1801875554
Payments from drug & device makers
Across 30 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$120
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$98
- Johnson & Johnson$90
- Biogen$63
- AstraZeneca$60
- Amarin Pharma, Inc.$56
- plus $165 from 7 others
What the payments were for
- Food & beverage$652100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $98 |
| Johnson & Johnson(2 entities) | 4 | $90 |
| Biogen | 3 | $63 |
| AstraZeneca | 2 | $60 |
| Amarin Pharma, Inc. | 4 | $56 |
| Boston Scientific | 1 | $35 |
| Pfizer | 2 | $29 |
| EMD Serono, Inc. | 1 | $25 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| AbbVie | 1 | $23 |
| Urgo Medical North America, LLC | 1 | $15 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
How this compares
$652 in reported general payments places this provider in the 85th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 60 | $522 |
| Cefadroxil | 27 | $288 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 20 | $163 |
| Mupirocin | 20 | $162 |
| Sulindac | 53 | $160 |
| Cefdinir | 12 | $156 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $101 |
| Dicyclomine Hcl | 16 | $58 |
| Tramadol Hcl | 37 | $54 |
| Meclizine Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Miami
- Sweha PatelMiami$827K
- Kunal AgarwalMiami$101K
- Patricia PanakosMiami$76K
- Daniel HerczMiami$40K
- David MishkinMiami$36K
- Sarah Angarita-JonesMiami$32K
- Miguel TrujilloMiami$19K
- Esteban OliveraKissimmee$15.7M
- Edgardo RiveraLeesburg$14.3M
- Mazyar RouhaniWeaston$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.